Investigating the level of Hba1c and insulin level in β-thalassemia patients

Background: β-thalassemia is an inherited blood disorder characterized by reduced or no synthesis of β globin chain, resulting in chronic anemia, so blood transfusion is required as curative therapy. Repeated blood transfusions lead to iron overload that can lead to multiple organ damage, including...

Full description

Bibliographic Details
Main Authors: Husnan Mujiburrahman, Qodri Santosa, Joko Setyono, Nendyah Roestijawati, Lantip Rujito
Format: Article
Language:English
Published: Universitas Muhammadiyah Purwokerto 2023-12-01
Series:Medisains
Subjects:
Online Access:https://jurnalnasional.ump.ac.id/index.php/medisains/article/view/18362
_version_ 1797371689395290112
author Husnan Mujiburrahman
Qodri Santosa
Joko Setyono
Nendyah Roestijawati
Lantip Rujito
author_facet Husnan Mujiburrahman
Qodri Santosa
Joko Setyono
Nendyah Roestijawati
Lantip Rujito
author_sort Husnan Mujiburrahman
collection DOAJ
description Background: β-thalassemia is an inherited blood disorder characterized by reduced or no synthesis of β globin chain, resulting in chronic anemia, so blood transfusion is required as curative therapy. Repeated blood transfusions lead to iron overload that can lead to multiple organ damage, including pancreatic organs. Objective: This study aimed to describe HbA1c and insulin levels of β-thalassemia patients. The study also tested whether there was a significant difference in insulin and HbA1c levels among patients with different β-thalassemia categories.  Method: This research was an analytic observational study. The samples were taken by total sampling and involved 30 patients, and the examination was carried out using the patient's blood plasma. Result: The study found that samples had low HbA1c levels. There was no significant mean difference (p>0.05) between insulin and HbA1c in the mild, moderate, and severe clinical degree groups. There was no significant difference in average (p>0.05) insulin and HbA1c in the thalassemia sufferers with allele β+ and β0 types. Conclusion: There was a decrease in insulin and HbA1c in patients with β-thalassemia, which may be caused by damage pancreatic organ damage.
first_indexed 2024-03-08T18:24:27Z
format Article
id doaj.art-5060e308cb914f63ae00aa0531088b2b
institution Directory Open Access Journal
issn 1693-7309
2621-2366
language English
last_indexed 2024-03-08T18:24:27Z
publishDate 2023-12-01
publisher Universitas Muhammadiyah Purwokerto
record_format Article
series Medisains
spelling doaj.art-5060e308cb914f63ae00aa0531088b2b2023-12-30T15:27:38ZengUniversitas Muhammadiyah PurwokertoMedisains1693-73092621-23662023-12-01213859010.30595/medisains.v21i3.183625755Investigating the level of Hba1c and insulin level in β-thalassemia patientsHusnan Mujiburrahman0Qodri Santosa1Joko Setyono2Nendyah Roestijawati3Lantip Rujito4faculty of medicine Universitas Jenderal SoedirmanFaculty of Medicine Universitas Jenderal SoedirmanFaculty of Medicine Universitas Jenderal SoedirmanFaculty of Medicine Universitas Jenderal SoedirmanFaculty of Medicine Universitas Jenderal SoedirmanBackground: β-thalassemia is an inherited blood disorder characterized by reduced or no synthesis of β globin chain, resulting in chronic anemia, so blood transfusion is required as curative therapy. Repeated blood transfusions lead to iron overload that can lead to multiple organ damage, including pancreatic organs. Objective: This study aimed to describe HbA1c and insulin levels of β-thalassemia patients. The study also tested whether there was a significant difference in insulin and HbA1c levels among patients with different β-thalassemia categories.  Method: This research was an analytic observational study. The samples were taken by total sampling and involved 30 patients, and the examination was carried out using the patient's blood plasma. Result: The study found that samples had low HbA1c levels. There was no significant mean difference (p>0.05) between insulin and HbA1c in the mild, moderate, and severe clinical degree groups. There was no significant difference in average (p>0.05) insulin and HbA1c in the thalassemia sufferers with allele β+ and β0 types. Conclusion: There was a decrease in insulin and HbA1c in patients with β-thalassemia, which may be caused by damage pancreatic organ damage.https://jurnalnasional.ump.ac.id/index.php/medisains/article/view/18362beta-thalassemiaglycated hemoglobininsulins
spellingShingle Husnan Mujiburrahman
Qodri Santosa
Joko Setyono
Nendyah Roestijawati
Lantip Rujito
Investigating the level of Hba1c and insulin level in β-thalassemia patients
Medisains
beta-thalassemia
glycated hemoglobin
insulins
title Investigating the level of Hba1c and insulin level in β-thalassemia patients
title_full Investigating the level of Hba1c and insulin level in β-thalassemia patients
title_fullStr Investigating the level of Hba1c and insulin level in β-thalassemia patients
title_full_unstemmed Investigating the level of Hba1c and insulin level in β-thalassemia patients
title_short Investigating the level of Hba1c and insulin level in β-thalassemia patients
title_sort investigating the level of hba1c and insulin level in β thalassemia patients
topic beta-thalassemia
glycated hemoglobin
insulins
url https://jurnalnasional.ump.ac.id/index.php/medisains/article/view/18362
work_keys_str_mv AT husnanmujiburrahman investigatingthelevelofhba1candinsulinlevelinbthalassemiapatients
AT qodrisantosa investigatingthelevelofhba1candinsulinlevelinbthalassemiapatients
AT jokosetyono investigatingthelevelofhba1candinsulinlevelinbthalassemiapatients
AT nendyahroestijawati investigatingthelevelofhba1candinsulinlevelinbthalassemiapatients
AT lantiprujito investigatingthelevelofhba1candinsulinlevelinbthalassemiapatients